{"transactions":[{"id":4636267,"issuer":{"id":5607,"kind":"organization","name":"SHOULDER INNOVATIONS, INC.","symbol":"SI"},"owners":[{"id":34840,"kind":"person","name":"Hykes Andrew","position":1,"cik":"0001806431","reported_name":"Hykes Andrew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-10-06T20:46:36.000Z","date":"2026-10-05","kind":"grant","planned":false,"acquired":true,"shares":669,"price":19.6,"value":13112.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of restricted stock units (\"RSUs\") received in lieu of cash retainer fees, which were fully vested as of the grant date.  Each RSU represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date. The Reporting Person voluntarily elected to defer receipt of the Common Stock issuable upon settlement of the RSUs until the Reporting Person's departure from the Board of Directors."}],"balance_after":7438,"source":{"system":"sec-edgar","filing":"0001806431-26-000005","document":"wk-form4_1791319594.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1806431/000180643126000005/wk-form4_1791319594.xml","form_type":"4"}},{"id":724107,"issuer":{"id":5607,"kind":"organization","name":"SHOULDER INNOVATIONS, INC.","symbol":"SI"},"owners":[{"id":34840,"kind":"person","name":"Hykes Andrew","position":1,"cik":"0001806431","reported_name":"Hykes Andrew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-29T21:07:09.000Z","date":"2026-06-26","kind":"grant","planned":false,"acquired":true,"shares":5046,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of restricted stock units (\"RSUs\"). The RSUs will vest on the earlier of the date of the annual meeting of stockholders to be held in 2027 or June 26, 2027. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date. The Reporting Person voluntarily elected to defer receipt of the Common Stock issuable upon settlement of the RSUs until the Reporting Person's departure from the Board of Directors."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,723 shares received without consideration as an in-kind distribution from Gilmartin Capital Fund I, LP.  In prior reports, the Reporting Person reported no beneficial ownership of Shoulder Innovations Common Stock."}],"balance_after":6769,"source":{"system":"sec-edgar","filing":"0001806431-26-000004","document":"wk-form4_1782767226.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1806431/000180643126000004/wk-form4_1782767226.xml","form_type":"4"}},{"id":1260261,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":34840,"kind":"person","name":"Hykes Andrew","position":1,"cik":"0001806431","reported_name":"Hykes Andrew","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Stock Options (Right to Buy)","published_at":"2025-02-20T01:01:55.000Z","date":"2025-02-19","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":44693,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"At the Effective Time, each outstanding option, whether vested or unvested, was cancelled and converted into the right to receive an amount of cash equal to the product of (i) the aggregate number of shares of Common Stock underlying such option immediately prior to the Effective Time, multiplied by (ii) the amount, if any, by which the Merger Consideration exceeds the exercise price per share of such option, subject to any applicable withholding taxes and in accordance with the terms of the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"At the Effective Time, each outstanding option, whether vested or unvested, was cancelled and converted into the right to receive an amount of cash equal to the product of (i) the aggregate number of shares of Common Stock underlying such option immediately prior to the Effective Time, multiplied by (ii) the amount, if any, by which the Merger Consideration exceeds the exercise price per share of such option, subject to any applicable withholding taxes and in accordance with the terms of the Merger Agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"At the Effective Time, each outstanding option, whether vested or unvested, was cancelled and converted into the right to receive an amount of cash equal to the product of (i) the aggregate number of shares of Common Stock underlying such option immediately prior to the Effective Time, multiplied by (ii) the amount, if any, by which the Merger Consideration exceeds the exercise price per share of such option, subject to any applicable withholding taxes and in accordance with the terms of the Merger Agreement."}],"balance_after":0,"derivative":{"exercise_price":58.44,"underlying":"Common Stock","underlying_shares":44693},"source":{"system":"sec-edgar","filing":"0001127602-25-005734","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1806431/000112760225005734/form4.xml","form_type":"4"}},{"id":1260260,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":34840,"kind":"person","name":"Hykes Andrew","position":1,"cik":"0001806431","reported_name":"Hykes Andrew","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Stock Options (Right to Buy)","published_at":"2025-02-20T01:01:55.000Z","date":"2025-02-19","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":36085,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"At the Effective Time, each outstanding option, whether vested or unvested, was cancelled and converted into the right to receive an amount of cash equal to the product of (i) the aggregate number of shares of Common Stock underlying such option immediately prior to the Effective Time, multiplied by (ii) the amount, if any, by which the Merger Consideration exceeds the exercise price per share of such option, subject to any applicable withholding taxes and in accordance with the terms of the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"At the Effective Time, each outstanding option, whether vested or unvested, was cancelled and converted into the right to receive an amount of cash equal to the product of (i) the aggregate number of shares of Common Stock underlying such option immediately prior to the Effective Time, multiplied by (ii) the amount, if any, by which the Merger Consideration exceeds the exercise price per share of such option, subject to any applicable withholding taxes and in accordance with the terms of the Merger Agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"At the Effective Time, each outstanding option, whether vested or unvested, was cancelled and converted into the right to receive an amount of cash equal to the product of (i) the aggregate number of shares of Common Stock underlying such option immediately prior to the Effective Time, multiplied by (ii) the amount, if any, by which the Merger Consideration exceeds the exercise price per share of such option, subject to any applicable withholding taxes and in accordance with the terms of the Merger Agreement."}],"balance_after":0,"derivative":{"exercise_price":56,"underlying":"Common Stock","underlying_shares":36085},"source":{"system":"sec-edgar","filing":"0001127602-25-005734","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1806431/000112760225005734/form4.xml","form_type":"4"}},{"id":1260259,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":34840,"kind":"person","name":"Hykes Andrew","position":1,"cik":"0001806431","reported_name":"Hykes Andrew","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-02-20T01:01:55.000Z","date":"2025-02-19","kind":"other","planned":false,"acquired":false,"shares":717637,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated January 6, 2025, by and among Stryker Corporation (\"Parent\"), Eagle 1 Merger Sub, Inc. (\"Merger Sub\"), and Inari Medical, Inc. (\"Issuer\") on February 19, 2025 (the \"Effective Time\"), Merger Sub merged with and into Issuer, with Issuer surviving as a wholly owned subsidiary of Parent upon consummation of the transactions contemplated by the Merger Agreement. At the Effective Time, each outstanding share of common stock of the Issuer (\"Common Stock\") was cancelled and converted into the right to receive $80.00 in cash (the \"Merger Consideration\"), without interest."},{"field":"shares","element":"transactionShares","label":"F3","text":"Includes 149,010 shares of restricted stock units (\"RSUs\"). At the Effective Time, each outstanding award of RSUs was canceled and converted into the right to receive an amount in cash equal to the product of the aggregate number of shares underlying such RSU immediately prior to the Effective Time, multiplied by the Merger Consideration."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated January 6, 2025, by and among Stryker Corporation (\"Parent\"), Eagle 1 Merger Sub, Inc. (\"Merger Sub\"), and Inari Medical, Inc. (\"Issuer\") on February 19, 2025 (the \"Effective Time\"), Merger Sub merged with and into Issuer, with Issuer surviving as a wholly owned subsidiary of Parent upon consummation of the transactions contemplated by the Merger Agreement. At the Effective Time, each outstanding share of common stock of the Issuer (\"Common Stock\") was cancelled and converted into the right to receive $80.00 in cash (the \"Merger Consideration\"), without interest."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001127602-25-005734","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1806431/000112760225005734/form4.xml","form_type":"4"}},{"id":1260258,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":34840,"kind":"person","name":"Hykes Andrew","position":1,"cik":"0001806431","reported_name":"Hykes Andrew","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-02-20T01:01:55.000Z","date":"2025-02-19","kind":"grant","planned":false,"acquired":true,"shares":20393,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to the Merger Agreement, at the Effective Time, these performance-based restricted stock units vested based on deemed achievement of maximum performance."},{"field":"shares","element":"transactionShares","label":"F2","text":"Pursuant to the Merger Agreement, at the Effective Time, these performance-based restricted stock units vested based on deemed achievement of maximum performance."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, at the Effective Time, these performance-based restricted stock units vested based on deemed achievement of maximum performance."}],"balance_after":717637,"source":{"system":"sec-edgar","filing":"0001127602-25-005734","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1806431/000112760225005734/form4.xml","form_type":"4"}},{"id":1260257,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":34840,"kind":"person","name":"Hykes Andrew","position":1,"cik":"0001806431","reported_name":"Hykes Andrew","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-02-20T01:01:55.000Z","date":"2025-02-19","kind":"other","planned":false,"acquired":false,"shares":1000,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated January 6, 2025, by and among Stryker Corporation (\"Parent\"), Eagle 1 Merger Sub, Inc. (\"Merger Sub\"), and Inari Medical, Inc. (\"Issuer\") on February 19, 2025 (the \"Effective Time\"), Merger Sub merged with and into Issuer, with Issuer surviving as a wholly owned subsidiary of Parent upon consummation of the transactions contemplated by the Merger Agreement. At the Effective Time, each outstanding share of common stock of the Issuer (\"Common Stock\") was cancelled and converted into the right to receive $80.00 in cash (the \"Merger Consideration\"), without interest."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated January 6, 2025, by and among Stryker Corporation (\"Parent\"), Eagle 1 Merger Sub, Inc. (\"Merger Sub\"), and Inari Medical, Inc. (\"Issuer\") on February 19, 2025 (the \"Effective Time\"), Merger Sub merged with and into Issuer, with Issuer surviving as a wholly owned subsidiary of Parent upon consummation of the transactions contemplated by the Merger Agreement. At the Effective Time, each outstanding share of common stock of the Issuer (\"Common Stock\") was cancelled and converted into the right to receive $80.00 in cash (the \"Merger Consideration\"), without interest."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001127602-25-005734","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1806431/000112760225005734/form4.xml","form_type":"4"}},{"id":1260256,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":34840,"kind":"person","name":"Hykes Andrew","position":1,"cik":"0001806431","reported_name":"Hykes Andrew","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-02-20T01:01:55.000Z","date":"2025-02-19","kind":"other","planned":false,"acquired":false,"shares":1550,"ownership":{"direct":false,"nature":"By Child 3"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated January 6, 2025, by and among Stryker Corporation (\"Parent\"), Eagle 1 Merger Sub, Inc. (\"Merger Sub\"), and Inari Medical, Inc. (\"Issuer\") on February 19, 2025 (the \"Effective Time\"), Merger Sub merged with and into Issuer, with Issuer surviving as a wholly owned subsidiary of Parent upon consummation of the transactions contemplated by the Merger Agreement. At the Effective Time, each outstanding share of common stock of the Issuer (\"Common Stock\") was cancelled and converted into the right to receive $80.00 in cash (the \"Merger Consideration\"), without interest."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated January 6, 2025, by and among Stryker Corporation (\"Parent\"), Eagle 1 Merger Sub, Inc. (\"Merger Sub\"), and Inari Medical, Inc. (\"Issuer\") on February 19, 2025 (the \"Effective Time\"), Merger Sub merged with and into Issuer, with Issuer surviving as a wholly owned subsidiary of Parent upon consummation of the transactions contemplated by the Merger Agreement. At the Effective Time, each outstanding share of common stock of the Issuer (\"Common Stock\") was cancelled and converted into the right to receive $80.00 in cash (the \"Merger Consideration\"), without interest."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001127602-25-005734","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1806431/000112760225005734/form4.xml","form_type":"4"}},{"id":1260255,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":34840,"kind":"person","name":"Hykes Andrew","position":1,"cik":"0001806431","reported_name":"Hykes Andrew","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-02-20T01:01:55.000Z","date":"2025-02-19","kind":"other","planned":false,"acquired":false,"shares":1550,"ownership":{"direct":false,"nature":"By Child 2"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated January 6, 2025, by and among Stryker Corporation (\"Parent\"), Eagle 1 Merger Sub, Inc. (\"Merger Sub\"), and Inari Medical, Inc. (\"Issuer\") on February 19, 2025 (the \"Effective Time\"), Merger Sub merged with and into Issuer, with Issuer surviving as a wholly owned subsidiary of Parent upon consummation of the transactions contemplated by the Merger Agreement. At the Effective Time, each outstanding share of common stock of the Issuer (\"Common Stock\") was cancelled and converted into the right to receive $80.00 in cash (the \"Merger Consideration\"), without interest."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated January 6, 2025, by and among Stryker Corporation (\"Parent\"), Eagle 1 Merger Sub, Inc. (\"Merger Sub\"), and Inari Medical, Inc. (\"Issuer\") on February 19, 2025 (the \"Effective Time\"), Merger Sub merged with and into Issuer, with Issuer surviving as a wholly owned subsidiary of Parent upon consummation of the transactions contemplated by the Merger Agreement. At the Effective Time, each outstanding share of common stock of the Issuer (\"Common Stock\") was cancelled and converted into the right to receive $80.00 in cash (the \"Merger Consideration\"), without interest."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001127602-25-005734","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1806431/000112760225005734/form4.xml","form_type":"4"}},{"id":1260254,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":34840,"kind":"person","name":"Hykes Andrew","position":1,"cik":"0001806431","reported_name":"Hykes Andrew","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-02-20T01:01:55.000Z","date":"2025-02-19","kind":"other","planned":false,"acquired":false,"shares":1550,"ownership":{"direct":false,"nature":"By Child 1"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated January 6, 2025, by and among Stryker Corporation (\"Parent\"), Eagle 1 Merger Sub, Inc. (\"Merger Sub\"), and Inari Medical, Inc. (\"Issuer\") on February 19, 2025 (the \"Effective Time\"), Merger Sub merged with and into Issuer, with Issuer surviving as a wholly owned subsidiary of Parent upon consummation of the transactions contemplated by the Merger Agreement. At the Effective Time, each outstanding share of common stock of the Issuer (\"Common Stock\") was cancelled and converted into the right to receive $80.00 in cash (the \"Merger Consideration\"), without interest."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated January 6, 2025, by and among Stryker Corporation (\"Parent\"), Eagle 1 Merger Sub, Inc. (\"Merger Sub\"), and Inari Medical, Inc. (\"Issuer\") on February 19, 2025 (the \"Effective Time\"), Merger Sub merged with and into Issuer, with Issuer surviving as a wholly owned subsidiary of Parent upon consummation of the transactions contemplated by the Merger Agreement. At the Effective Time, each outstanding share of common stock of the Issuer (\"Common Stock\") was cancelled and converted into the right to receive $80.00 in cash (the \"Merger Consideration\"), without interest."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001127602-25-005734","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1806431/000112760225005734/form4.xml","form_type":"4"}},{"id":1271798,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":34840,"kind":"person","name":"Hykes Andrew","position":1,"cik":"0001806431","reported_name":"Hykes Andrew","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Stock Option","published_at":"2025-02-12T21:42:56.000Z","date":"2025-02-10","kind":"exercise","planned":false,"acquired":false,"shares":16719,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option became fully vested and exercisable as of January 1, 2023."}],"balance_after":0,"derivative":{"exercise_price":0.4569,"expiration_date":"2029-03-12","underlying":"Common Stock","underlying_shares":16719},"source":{"system":"sec-edgar","filing":"0001127602-25-004391","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1806431/000112760225004391/form4.xml","form_type":"4"}},{"id":1271797,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":34840,"kind":"person","name":"Hykes Andrew","position":1,"cik":"0001806431","reported_name":"Hykes Andrew","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Stock Option","published_at":"2025-02-12T21:42:56.000Z","date":"2025-02-10","kind":"exercise","planned":false,"acquired":false,"shares":16719,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option became fully vested and exercisable as of January 1, 2024."}],"balance_after":0,"derivative":{"exercise_price":6.4546,"expiration_date":"2030-01-17","underlying":"Common Stock","underlying_shares":16719},"source":{"system":"sec-edgar","filing":"0001127602-25-004391","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1806431/000112760225004391/form4.xml","form_type":"4"}},{"id":1271796,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":34840,"kind":"person","name":"Hykes Andrew","position":1,"cik":"0001806431","reported_name":"Hykes Andrew","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Stock Options (Right to Buy)","published_at":"2025-02-12T21:42:56.000Z","date":"2025-02-10","kind":"exercise","planned":false,"acquired":false,"shares":161100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option became fully vested and exercisable as of March 29, 2022."}],"balance_after":0,"derivative":{"exercise_price":0.4284,"expiration_date":"2028-05-03","underlying":"Common Stock","underlying_shares":161100},"source":{"system":"sec-edgar","filing":"0001127602-25-004391","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1806431/000112760225004391/form4.xml","form_type":"4"}},{"id":1271795,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":34840,"kind":"person","name":"Hykes Andrew","position":1,"cik":"0001806431","reported_name":"Hykes Andrew","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-02-12T21:42:56.000Z","date":"2025-02-10","kind":"exercise","planned":false,"acquired":true,"shares":16719,"price":0.4569,"value":7638.9111,"ownership":{"direct":true},"balance_after":697244,"source":{"system":"sec-edgar","filing":"0001127602-25-004391","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1806431/000112760225004391/form4.xml","form_type":"4"}},{"id":1271794,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":34840,"kind":"person","name":"Hykes Andrew","position":1,"cik":"0001806431","reported_name":"Hykes Andrew","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-02-12T21:42:56.000Z","date":"2025-02-10","kind":"exercise","planned":false,"acquired":true,"shares":16719,"price":6.4546,"value":107914.4574,"ownership":{"direct":true},"balance_after":680525,"source":{"system":"sec-edgar","filing":"0001127602-25-004391","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1806431/000112760225004391/form4.xml","form_type":"4"}},{"id":1271793,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":34840,"kind":"person","name":"Hykes Andrew","position":1,"cik":"0001806431","reported_name":"Hykes Andrew","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-02-12T21:42:56.000Z","date":"2025-02-10","kind":"exercise","planned":false,"acquired":true,"shares":161100,"price":0.4284,"value":69015.24,"ownership":{"direct":true},"balance_after":663806,"source":{"system":"sec-edgar","filing":"0001127602-25-004391","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1806431/000112760225004391/form4.xml","form_type":"4"}},{"id":1280364,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":34840,"kind":"person","name":"Hykes Andrew","position":1,"cik":"0001806431","reported_name":"Hykes Andrew","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-02-06T21:47:52.000Z","date":"2025-02-04","kind":"grant","planned":false,"acquired":true,"shares":67282,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") awarded to the reporting person, with a vesting commencement date of January 1, 2025 (the \"Vesting Commencement Date\"). 1/16th of the RSUs shall vest on each quarterly anniversary of the Vesting Commencement Date, subject to continued service through the applicable vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 523 shares acquired on January 31, 2025, under the Company's Employee Stock Purchase Plan."}],"balance_after":502706,"source":{"system":"sec-edgar","filing":"0001127602-25-003433","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1806431/000112760225003433/form4.xml","form_type":"4"}},{"id":1315039,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":34840,"kind":"person","name":"Hykes Andrew","position":1,"cik":"0001806431","reported_name":"Hykes Andrew","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-01-03T21:51:24.000Z","date":"2025-01-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":1319,"price":51.05,"value":67334.95,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Consists of shares of common stock retained by Inari to satisfy the reporting person's tax obligation in connection with the vesting of restricted share units awarded in 2024."}],"balance_after":434901,"source":{"system":"sec-edgar","filing":"0001127602-25-000485","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1806431/000112760225000485/form4.xml","form_type":"4"}},{"id":1315038,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":34840,"kind":"person","name":"Hykes Andrew","position":1,"cik":"0001806431","reported_name":"Hykes Andrew","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-01-03T21:51:24.000Z","date":"2025-01-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":1632,"price":51.05,"value":83313.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Consists of shares of common stock retained by Inari to satisfy the reporting person's tax obligation in connection with the vesting of restricted share units awarded in 2023."}],"balance_after":436220,"source":{"system":"sec-edgar","filing":"0001127602-25-000485","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1806431/000112760225000485/form4.xml","form_type":"4"}},{"id":1315037,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":34840,"kind":"person","name":"Hykes Andrew","position":1,"cik":"0001806431","reported_name":"Hykes Andrew","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-01-03T21:51:24.000Z","date":"2025-01-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":949,"price":51.05,"value":48446.45,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Consists of shares of common stock retained by Inari to satisfy the reporting person's tax obligation in connection with the vesting of restricted share units awarded in 2022."}],"balance_after":437852,"source":{"system":"sec-edgar","filing":"0001127602-25-000485","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1806431/000112760225000485/form4.xml","form_type":"4"}},{"id":1315036,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":34840,"kind":"person","name":"Hykes Andrew","position":1,"cik":"0001806431","reported_name":"Hykes Andrew","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-01-03T21:51:24.000Z","date":"2025-01-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":509,"price":51.05,"value":25984.45,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of shares of common stock retained by Inari to satisfy the reporting person's tax obligation in connection with the vesting of restricted share units awarded in 2021."}],"balance_after":438801,"source":{"system":"sec-edgar","filing":"0001127602-25-000485","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1806431/000112760225000485/form4.xml","form_type":"4"}},{"id":1324219,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":34840,"kind":"person","name":"Hykes Andrew","position":1,"cik":"0001806431","reported_name":"Hykes Andrew","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-12-21T00:18:26.000Z","date":"2024-12-20","kind":"sale","planned":true,"acquired":false,"shares":600,"price":55.65,"value":33390.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 13, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $55.56 to $55.75. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":439310,"source":{"system":"sec-edgar","filing":"0001127602-24-029927","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1806431/000112760224029927/form4.xml","form_type":"4"}},{"id":1324218,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":34840,"kind":"person","name":"Hykes Andrew","position":1,"cik":"0001806431","reported_name":"Hykes Andrew","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-12-21T00:18:26.000Z","date":"2024-12-20","kind":"sale","planned":true,"acquired":false,"shares":2400,"price":55.2,"value":132480.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 13, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $54.56 to $55.47. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":439910,"source":{"system":"sec-edgar","filing":"0001127602-24-029927","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1806431/000112760224029927/form4.xml","form_type":"4"}},{"id":1354467,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":34840,"kind":"person","name":"Hykes Andrew","position":1,"cik":"0001806431","reported_name":"Hykes Andrew","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-11-22T21:56:59.000Z","date":"2024-11-20","kind":"sale","planned":true,"acquired":false,"shares":3000,"price":50.83,"value":152490.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 13, 2023."}],"balance_after":442310,"source":{"system":"sec-edgar","filing":"0001127602-24-027912","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1806431/000112760224027912/form4.xml","form_type":"4"}},{"id":1378855,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":34840,"kind":"person","name":"Hykes Andrew","position":1,"cik":"0001806431","reported_name":"Hykes Andrew","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-10-31T22:29:14.000Z","date":"2024-10-29","kind":"sale","planned":true,"acquired":false,"shares":3000,"price":50,"value":150000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 13, 2023."}],"balance_after":445310,"source":{"system":"sec-edgar","filing":"0001127602-24-026168","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1806431/000112760224026168/form4.xml","form_type":"4"}},{"id":1392154,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":34840,"kind":"person","name":"Hykes Andrew","position":1,"cik":"0001806431","reported_name":"Hykes Andrew","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-10-03T20:36:41.000Z","date":"2024-10-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":1292,"price":40.63,"value":52493.96,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Consists of shares of common stock retained by Inari to satisfy the reporting person's tax obligation in connection with the vesting of restricted share units awarded in 2024."}],"balance_after":448310,"source":{"system":"sec-edgar","filing":"0001127602-24-025128","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1806431/000112760224025128/form4.xml","form_type":"4"}},{"id":1392153,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":34840,"kind":"person","name":"Hykes Andrew","position":1,"cik":"0001806431","reported_name":"Hykes Andrew","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-10-03T20:36:41.000Z","date":"2024-10-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":1475,"price":40.63,"value":59929.25,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Consists of shares of common stock retained by Inari to satisfy the reporting person's tax obligation in connection with the vesting of restricted share units awarded in 2023."}],"balance_after":449602,"source":{"system":"sec-edgar","filing":"0001127602-24-025128","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1806431/000112760224025128/form4.xml","form_type":"4"}},{"id":1392152,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":34840,"kind":"person","name":"Hykes Andrew","position":1,"cik":"0001806431","reported_name":"Hykes Andrew","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-10-03T20:36:41.000Z","date":"2024-10-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":947,"price":40.63,"value":38476.61,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Consists of shares of common stock retained by Inari to satisfy the reporting person's tax obligation in connection with the vesting of restricted share units awarded in 2022."}],"balance_after":451077,"source":{"system":"sec-edgar","filing":"0001127602-24-025128","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1806431/000112760224025128/form4.xml","form_type":"4"}},{"id":1392151,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":34840,"kind":"person","name":"Hykes Andrew","position":1,"cik":"0001806431","reported_name":"Hykes Andrew","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-10-03T20:36:41.000Z","date":"2024-10-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":508,"price":40.63,"value":20640.04,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of shares of common stock retained by Inari to satisfy the reporting person's tax obligation in connection with the vesting of restricted share units awarded in 2021."}],"balance_after":452024,"source":{"system":"sec-edgar","filing":"0001127602-24-025128","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1806431/000112760224025128/form4.xml","form_type":"4"}},{"id":1425405,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":34840,"kind":"person","name":"Hykes Andrew","position":1,"cik":"0001806431","reported_name":"Hykes Andrew","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-08-22T20:34:54.000Z","date":"2024-08-20","kind":"sale","planned":true,"acquired":false,"shares":3000,"price":50,"value":150000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 13, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 280 shares acquired on July 31, 2024 through the Issuer's Employee Stock Purchase Program."}],"balance_after":452532,"source":{"system":"sec-edgar","filing":"0001127602-24-022796","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1806431/000112760224022796/form4.xml","form_type":"4"}},{"id":1449388,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":34840,"kind":"person","name":"Hykes Andrew","position":1,"cik":"0001806431","reported_name":"Hykes Andrew","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-07-24T21:04:13.000Z","date":"2024-07-22","kind":"sale","planned":true,"acquired":false,"shares":3000,"price":55.23,"value":165690.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 13, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $54.92 to $55.59. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":455252,"source":{"system":"sec-edgar","filing":"0001127602-24-020966","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1806431/000112760224020966/form4.xml","form_type":"4"}},{"id":1460176,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":34840,"kind":"person","name":"Hykes Andrew","position":1,"cik":"0001806431","reported_name":"Hykes Andrew","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-07-03T19:04:14.000Z","date":"2024-07-01","kind":"tax_withholding","planned":true,"acquired":false,"shares":1292,"price":50.19,"value":64845.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F6","text":"Consists of shares of common stock retained by Inari to satisfy the reporting person's tax obligation in connection with the vesting of restricted share units awarded in 2024."}],"balance_after":458252,"source":{"system":"sec-edgar","filing":"0001127602-24-020038","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1806431/000112760224020038/form4.xml","form_type":"4"}},{"id":1460175,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":34840,"kind":"person","name":"Hykes Andrew","position":1,"cik":"0001806431","reported_name":"Hykes Andrew","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-07-03T19:04:14.000Z","date":"2024-07-01","kind":"tax_withholding","planned":true,"acquired":false,"shares":1475,"price":50.19,"value":74030.25,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Consists of shares of common stock retained by Inari to satisfy the reporting person's tax obligation in connection with the vesting of restricted share units awarded in 2023."}],"balance_after":459544,"source":{"system":"sec-edgar","filing":"0001127602-24-020038","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1806431/000112760224020038/form4.xml","form_type":"4"}},{"id":1460174,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":34840,"kind":"person","name":"Hykes Andrew","position":1,"cik":"0001806431","reported_name":"Hykes Andrew","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-07-03T19:04:14.000Z","date":"2024-07-01","kind":"tax_withholding","planned":true,"acquired":false,"shares":947,"price":50.19,"value":47529.93,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Consists of shares of common stock retained by Inari to satisfy the reporting person's tax obligation in connection with the vesting of restricted share units awarded in 2022."}],"balance_after":461019,"source":{"system":"sec-edgar","filing":"0001127602-24-020038","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1806431/000112760224020038/form4.xml","form_type":"4"}},{"id":1460173,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":34840,"kind":"person","name":"Hykes Andrew","position":1,"cik":"0001806431","reported_name":"Hykes Andrew","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-07-03T19:04:14.000Z","date":"2024-07-01","kind":"tax_withholding","planned":true,"acquired":false,"shares":508,"price":50.19,"value":25496.52,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Consists of shares of common stock retained by Inari to satisfy the reporting person's tax obligation in connection with the vesting of restricted share units awarded in 2021."}],"balance_after":461966,"source":{"system":"sec-edgar","filing":"0001127602-24-020038","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1806431/000112760224020038/form4.xml","form_type":"4"}},{"id":1460172,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":34840,"kind":"person","name":"Hykes Andrew","position":1,"cik":"0001806431","reported_name":"Hykes Andrew","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-07-03T19:04:14.000Z","date":"2024-07-01","kind":"sale","planned":true,"acquired":false,"shares":3000,"price":50.08,"value":150240.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 13, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $50.00 to $50.15. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":462474,"source":{"system":"sec-edgar","filing":"0001127602-24-020038","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1806431/000112760224020038/form4.xml","form_type":"4"}},{"id":1497980,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":34840,"kind":"person","name":"Hykes Andrew","position":1,"cik":"0001806431","reported_name":"Hykes Andrew","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-05-30T23:14:37.000Z","date":"2024-05-28","kind":"sale","planned":true,"acquired":false,"shares":3000,"price":50,"value":150000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 13, 2023."}],"balance_after":465474,"source":{"system":"sec-edgar","filing":"0001127602-24-017012","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1806431/000112760224017012/form4.xml","form_type":"4"}},{"id":1549926,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":34840,"kind":"person","name":"Hykes Andrew","position":1,"cik":"0001806431","reported_name":"Hykes Andrew","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-04-03T20:43:06.000Z","date":"2024-04-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":1292,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Consists of shares of common stock retained by Inari to satisfy the reporting person's tax obligation in connection with the vesting of restricted share units awarded in 2024."}],"balance_after":468474,"source":{"system":"sec-edgar","filing":"0001127602-24-012247","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1806431/000112760224012247/form4.xml","form_type":"4"}},{"id":1549925,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":34840,"kind":"person","name":"Hykes Andrew","position":1,"cik":"0001806431","reported_name":"Hykes Andrew","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-04-03T20:43:06.000Z","date":"2024-04-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":1475,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Consists of shares of common stock retained by Inari to satisfy the reporting person's tax obligation in connection with the vesting of restricted share units awarded in 2023."}],"balance_after":469766,"source":{"system":"sec-edgar","filing":"0001127602-24-012247","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1806431/000112760224012247/form4.xml","form_type":"4"}},{"id":1549924,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":34840,"kind":"person","name":"Hykes Andrew","position":1,"cik":"0001806431","reported_name":"Hykes Andrew","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-04-03T20:43:06.000Z","date":"2024-04-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":947,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Consists of shares of common stock retained by Inari to satisfy the reporting person's tax obligation in connection with the vesting of restricted share units awarded in 2022."}],"balance_after":471241,"source":{"system":"sec-edgar","filing":"0001127602-24-012247","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1806431/000112760224012247/form4.xml","form_type":"4"}},{"id":1549923,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":34840,"kind":"person","name":"Hykes Andrew","position":1,"cik":"0001806431","reported_name":"Hykes Andrew","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-04-03T20:43:06.000Z","date":"2024-04-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":508,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of shares of common stock retained by Inari to satisfy the reporting person's tax obligation in connection with the vesting of restricted share units awarded in 2021."}],"balance_after":472188,"source":{"system":"sec-edgar","filing":"0001127602-24-012247","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1806431/000112760224012247/form4.xml","form_type":"4"}},{"id":1629523,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":34840,"kind":"person","name":"Hykes Andrew","position":1,"cik":"0001806431","reported_name":"Hykes Andrew","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Stock Options (Right to Buy)","published_at":"2024-02-22T02:52:32.000Z","date":"2024-02-16","kind":"grant","planned":false,"acquired":true,"shares":44693,"price":58.44,"value":2611858.92,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents options to purchase shares of Issuer common stock which were granted on February 16, 2024 under the Issuer's 2020 Incentive Award Plan and are scheduled to become vested and exercisable on a quarterly basis, with the first tranche vesting on April 1, 2024."}],"balance_after":44693,"derivative":{"exercise_price":58.44,"expiration_date":"2031-02-15","underlying":"Common Stock","underlying_shares":44693},"source":{"system":"sec-edgar","filing":"0001127602-24-006227","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1806431/000112760224006227/form4.xml","form_type":"4"}},{"id":1629522,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":34840,"kind":"person","name":"Hykes Andrew","position":1,"cik":"0001806431","reported_name":"Hykes Andrew","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-02-22T02:52:32.000Z","date":"2024-02-16","kind":"grant","planned":false,"acquired":true,"shares":40786,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents annual restricted stock units (\"RSUs\") awarded to the reporting person, with a vesting commencement date of January 1, 2024 (the \"Vesting Commencement Date\"). 1/16th of the RSUs shall vest on each quarterly anniversary of the Vesting Commencement Date, subject to continued service through the applicable vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 156 shares acquired on January 31, 2024, under the Company's Employee Stock Purchase Plan."}],"balance_after":472696,"source":{"system":"sec-edgar","filing":"0001127602-24-006227","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1806431/000112760224006227/form4.xml","form_type":"4"}},{"id":1692908,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":34840,"kind":"person","name":"Hykes Andrew","position":1,"cik":"0001806431","reported_name":"Hykes Andrew","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-01-03T17:29:57.000Z","date":"2024-01-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":1610,"price":64.92,"value":104521.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Consists of shares of common stock retained by Inari to satisfy the reporting person's tax obligation in connection with the vesting of restricted share units awarded in 2023."}],"balance_after":431754,"source":{"system":"sec-edgar","filing":"0001127602-24-000288","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1806431/000112760224000288/form4.xml","form_type":"4"}},{"id":1692907,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":34840,"kind":"person","name":"Hykes Andrew","position":1,"cik":"0001806431","reported_name":"Hykes Andrew","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-01-03T17:29:57.000Z","date":"2024-01-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":945,"price":64.92,"value":61349.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Consists of shares of common stock retained by Inari to satisfy the reporting person's tax obligation in connection with the vesting of restricted share units awarded in 2022."}],"balance_after":433364,"source":{"system":"sec-edgar","filing":"0001127602-24-000288","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1806431/000112760224000288/form4.xml","form_type":"4"}},{"id":1692906,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":34840,"kind":"person","name":"Hykes Andrew","position":1,"cik":"0001806431","reported_name":"Hykes Andrew","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-01-03T17:29:57.000Z","date":"2024-01-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":508,"price":64.92,"value":32979.36,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of shares of common stock retained by Inari to satisfy the reporting person's tax obligation in connection with the vesting of restricted share units awarded in 2021."}],"balance_after":434309,"source":{"system":"sec-edgar","filing":"0001127602-24-000288","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1806431/000112760224000288/form4.xml","form_type":"4"}},{"id":1736896,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":34840,"kind":"person","name":"Hykes Andrew","position":1,"cik":"0001806431","reported_name":"Hykes Andrew","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-11-18T00:17:26.000Z","date":"2023-11-16","kind":"sale","planned":false,"acquired":false,"shares":16415,"price":60.2,"value":988183.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the distribution and settlement of previously vested Restricted Stock Units (RSUs). The sale to cover transactions were irrevocably agreed to in writing by the Reporting Person prior to the distribution of the RSUs to satisfy the tax withholding obligations and do not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $59.93 to $60.65. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":434817,"source":{"system":"sec-edgar","filing":"0001127602-23-027915","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1806431/000112760223027915/form4.xml","form_type":"4"}},{"id":1736895,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":34840,"kind":"person","name":"Hykes Andrew","position":1,"cik":"0001806431","reported_name":"Hykes Andrew","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-11-18T00:17:26.000Z","date":"2023-11-16","kind":"sale","planned":false,"acquired":false,"shares":21033,"price":59.53,"value":1252094.49,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the distribution and settlement of previously vested Restricted Stock Units (RSUs). The sale to cover transactions were irrevocably agreed to in writing by the Reporting Person prior to the distribution of the RSUs to satisfy the tax withholding obligations and do not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $58.93 to $59.92. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":451232,"source":{"system":"sec-edgar","filing":"0001127602-23-027915","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1806431/000112760223027915/form4.xml","form_type":"4"}},{"id":1767704,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":34840,"kind":"person","name":"Hykes Andrew","position":1,"cik":"0001806431","reported_name":"Hykes Andrew","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-10-04T01:26:19.000Z","date":"2023-10-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":1443,"price":65.4,"value":94372.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Consists of shares of common stock retained by Inari to satisfy the reporting person's tax obligation in connection with the vesting of restricted share units awarded in 2023."}],"balance_after":472265,"source":{"system":"sec-edgar","filing":"0001127602-23-025402","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1806431/000112760223025402/form4.xml","form_type":"4"}},{"id":1767703,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":34840,"kind":"person","name":"Hykes Andrew","position":1,"cik":"0001806431","reported_name":"Hykes Andrew","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-10-04T01:26:19.000Z","date":"2023-10-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":927,"price":65.4,"value":60625.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Consists of shares of common stock retained by Inari to satisfy the reporting person's tax obligation in connection with the vesting of restricted share units awarded in 2022."}],"balance_after":473708,"source":{"system":"sec-edgar","filing":"0001127602-23-025402","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1806431/000112760223025402/form4.xml","form_type":"4"}},{"id":1767702,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":34840,"kind":"person","name":"Hykes Andrew","position":1,"cik":"0001806431","reported_name":"Hykes Andrew","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-10-04T01:26:19.000Z","date":"2023-10-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":497,"price":65.4,"value":32503.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of shares of common stock retained by Inari to satisfy the reporting person's tax obligation in connection with the vesting of restricted share units awarded in 2021."}],"balance_after":474635,"source":{"system":"sec-edgar","filing":"0001127602-23-025402","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1806431/000112760223025402/form4.xml","form_type":"4"}},{"id":1802008,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":34840,"kind":"person","name":"Hykes Andrew","position":1,"cik":"0001806431","reported_name":"Hykes Andrew","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-08-18T21:05:02.000Z","date":"2023-08-16","kind":"sale","planned":false,"acquired":false,"shares":595,"price":68.03,"value":40477.85,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the distribution and settlement of previously vested Restricted Stock Units (RSUs). The sale to cover transactions were irrevocably agreed to in writing by the Reporting Person prior to the distribution of the RSUs to satisfy the tax withholding obligations and do not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $67.89 to $68.22. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Includes 199 shares acquired on July 31, 2023, under the Company's Employee Stock Purchase Plan."}],"balance_after":475132,"source":{"system":"sec-edgar","filing":"0001127602-23-022961","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1806431/000112760223022961/form4.xml","form_type":"4"}},{"id":1802007,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":34840,"kind":"person","name":"Hykes Andrew","position":1,"cik":"0001806431","reported_name":"Hykes Andrew","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-08-18T21:05:02.000Z","date":"2023-08-16","kind":"sale","planned":false,"acquired":false,"shares":9906,"price":67.31,"value":666772.86,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the distribution and settlement of previously vested Restricted Stock Units (RSUs). The sale to cover transactions were irrevocably agreed to in writing by the Reporting Person prior to the distribution of the RSUs to satisfy the tax withholding obligations and do not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $66.88 to $67.84. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":475727,"source":{"system":"sec-edgar","filing":"0001127602-23-022961","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1806431/000112760223022961/form4.xml","form_type":"4"}},{"id":1802006,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":34840,"kind":"person","name":"Hykes Andrew","position":1,"cik":"0001806431","reported_name":"Hykes Andrew","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-08-18T21:05:02.000Z","date":"2023-08-16","kind":"sale","planned":false,"acquired":false,"shares":8009,"price":66.32,"value":531156.88,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the distribution and settlement of previously vested Restricted Stock Units (RSUs). The sale to cover transactions were irrevocably agreed to in writing by the Reporting Person prior to the distribution of the RSUs to satisfy the tax withholding obligations and do not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $65.88 to $66.87. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":485633,"source":{"system":"sec-edgar","filing":"0001127602-23-022961","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1806431/000112760223022961/form4.xml","form_type":"4"}},{"id":1802005,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":34840,"kind":"person","name":"Hykes Andrew","position":1,"cik":"0001806431","reported_name":"Hykes Andrew","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-08-18T21:05:02.000Z","date":"2023-08-16","kind":"sale","planned":false,"acquired":false,"shares":18166,"price":65.31,"value":1186421.46,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the distribution and settlement of previously vested Restricted Stock Units (RSUs). The sale to cover transactions were irrevocably agreed to in writing by the Reporting Person prior to the distribution of the RSUs to satisfy the tax withholding obligations and do not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $64.88 to $65.85. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":493642,"source":{"system":"sec-edgar","filing":"0001127602-23-022961","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1806431/000112760223022961/form4.xml","form_type":"4"}},{"id":1836524,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":34840,"kind":"person","name":"Hykes Andrew","position":1,"cik":"0001806431","reported_name":"Hykes Andrew","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-07-05T22:16:26.000Z","date":"2023-07-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":1006,"price":58.14,"value":58488.84,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Consists of shares of common stock retained by Inari to satisfy the reporting person's tax obligation in connection with the vesting of restricted share units awarded in 2023."}],"balance_after":511609,"source":{"system":"sec-edgar","filing":"0001127602-23-020265","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1806431/000112760223020265/form4.xml","form_type":"4"}},{"id":1836523,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":34840,"kind":"person","name":"Hykes Andrew","position":1,"cik":"0001806431","reported_name":"Hykes Andrew","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-07-05T22:16:26.000Z","date":"2023-07-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":646,"price":58.14,"value":37558.44,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Consists of shares of common stock retained by Inari to satisfy the reporting person's tax obligation in connection with the vesting of restricted share units awarded in 2022."}],"balance_after":512615,"source":{"system":"sec-edgar","filing":"0001127602-23-020265","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1806431/000112760223020265/form4.xml","form_type":"4"}},{"id":1836522,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":34840,"kind":"person","name":"Hykes Andrew","position":1,"cik":"0001806431","reported_name":"Hykes Andrew","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-07-05T22:16:26.000Z","date":"2023-07-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":347,"price":58.14,"value":20174.58,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of shares of common stock retained by Inari to satisfy the reporting person's tax obligation in connection with the vesting of restricted share units awarded in 2021."}],"balance_after":513261,"source":{"system":"sec-edgar","filing":"0001127602-23-020265","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1806431/000112760223020265/form4.xml","form_type":"4"}},{"id":1886958,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":34840,"kind":"person","name":"Hykes Andrew","position":1,"cik":"0001806431","reported_name":"Hykes Andrew","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-05-19T00:16:46.000Z","date":"2023-05-17","kind":"sale","planned":false,"acquired":false,"shares":51,"price":69.19,"value":3528.69,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the distribution and settlement of previously vested Restricted Stock Units (RSUs). The sale to cover transactions were irrevocably agreed to in writing by the Reporting Person prior to the distribution of the RSUs to satisfy the tax withholding obligations and do not represent a discretionary transaction by the Reporting Person."}],"balance_after":513608,"source":{"system":"sec-edgar","filing":"0001127602-23-016225","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1806431/000112760223016225/form4.xml","form_type":"4"}},{"id":1886957,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":34840,"kind":"person","name":"Hykes Andrew","position":1,"cik":"0001806431","reported_name":"Hykes Andrew","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-05-19T00:16:46.000Z","date":"2023-05-17","kind":"sale","planned":false,"acquired":false,"shares":2630,"price":69.19,"value":181969.7,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the distribution and settlement of previously vested Restricted Stock Units (RSUs). The sale to cover transactions were irrevocably agreed to in writing by the Reporting Person prior to the distribution of the RSUs to satisfy the tax withholding obligations and do not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $70.27 to $71.25. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":513659,"source":{"system":"sec-edgar","filing":"0001127602-23-016225","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1806431/000112760223016225/form4.xml","form_type":"4"}},{"id":1886956,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":34840,"kind":"person","name":"Hykes Andrew","position":1,"cik":"0001806431","reported_name":"Hykes Andrew","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-05-19T00:16:46.000Z","date":"2023-05-17","kind":"sale","planned":false,"acquired":false,"shares":16079,"price":69.19,"value":1112506.01,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the distribution and settlement of previously vested Restricted Stock Units (RSUs). The sale to cover transactions were irrevocably agreed to in writing by the Reporting Person prior to the distribution of the RSUs to satisfy the tax withholding obligations and do not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $69.07 to $69.96. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":516289,"source":{"system":"sec-edgar","filing":"0001127602-23-016225","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1806431/000112760223016225/form4.xml","form_type":"4"}},{"id":1886955,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":34840,"kind":"person","name":"Hykes Andrew","position":1,"cik":"0001806431","reported_name":"Hykes Andrew","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-05-19T00:16:46.000Z","date":"2023-05-16","kind":"sale","planned":false,"acquired":false,"shares":153,"price":70.87,"value":10843.11,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the distribution and settlement of previously vested Restricted Stock Units (RSUs). The sale to cover transactions were irrevocably agreed to in writing by the Reporting Person prior to the distribution of the RSUs to satisfy the tax withholding obligations and do not represent a discretionary transaction by the Reporting Person."}],"balance_after":532368,"source":{"system":"sec-edgar","filing":"0001127602-23-016225","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1806431/000112760223016225/form4.xml","form_type":"4"}},{"id":1886954,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":34840,"kind":"person","name":"Hykes Andrew","position":1,"cik":"0001806431","reported_name":"Hykes Andrew","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-05-19T00:16:46.000Z","date":"2023-05-16","kind":"sale","planned":false,"acquired":false,"shares":16945,"price":70.87,"value":1200892.15,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the distribution and settlement of previously vested Restricted Stock Units (RSUs). The sale to cover transactions were irrevocably agreed to in writing by the Reporting Person prior to the distribution of the RSUs to satisfy the tax withholding obligations and do not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $70.27 to $71.25. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":532521,"source":{"system":"sec-edgar","filing":"0001127602-23-016225","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1806431/000112760223016225/form4.xml","form_type":"4"}},{"id":1886953,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":34840,"kind":"person","name":"Hykes Andrew","position":1,"cik":"0001806431","reported_name":"Hykes Andrew","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-05-19T00:16:46.000Z","date":"2023-05-16","kind":"sale","planned":false,"acquired":false,"shares":818,"price":70.87,"value":57971.66,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the distribution and settlement of previously vested Restricted Stock Units (RSUs). The sale to cover transactions were irrevocably agreed to in writing by the Reporting Person prior to the distribution of the RSUs to satisfy the tax withholding obligations and do not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $69.07 to $69.96. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":549466,"source":{"system":"sec-edgar","filing":"0001127602-23-016225","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1806431/000112760223016225/form4.xml","form_type":"4"}},{"id":1928582,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":34840,"kind":"person","name":"Hykes Andrew","position":1,"cik":"0001806431","reported_name":"Hykes Andrew","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-04-05T00:09:07.000Z","date":"2023-04-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":1006,"price":61.74,"value":62110.44,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Consists of shares of common stock retained by Inari to satisfy the reporting person's tax obligation in connection with the vesting of restricted share units awarded in 2023."}],"balance_after":550284,"source":{"system":"sec-edgar","filing":"0001127602-23-012450","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1806431/000112760223012450/form4.xml","form_type":"4"}},{"id":1928581,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":34840,"kind":"person","name":"Hykes Andrew","position":1,"cik":"0001806431","reported_name":"Hykes Andrew","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-04-05T00:09:07.000Z","date":"2023-04-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":646,"price":61.74,"value":39884.04,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Consists of shares of common stock retained by Inari to satisfy the reporting person's tax obligation in connection with the vesting of restricted share units awarded in 2022."}],"balance_after":551290,"source":{"system":"sec-edgar","filing":"0001127602-23-012450","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1806431/000112760223012450/form4.xml","form_type":"4"}},{"id":1928580,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":34840,"kind":"person","name":"Hykes Andrew","position":1,"cik":"0001806431","reported_name":"Hykes Andrew","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-04-05T00:09:07.000Z","date":"2023-04-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":347,"price":61.74,"value":21423.78,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of shares of common stock retained by Inari to satisfy the reporting person's tax obligation in connection with the vesting of restricted share units awarded in 2021."}],"balance_after":551936,"source":{"system":"sec-edgar","filing":"0001127602-23-012450","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1806431/000112760223012450/form4.xml","form_type":"4"}},{"id":1943186,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":34840,"kind":"person","name":"Hykes Andrew","position":1,"cik":"0001806431","reported_name":"Hykes Andrew","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-03-21T20:35:29.000Z","date":"2023-03-20","kind":"sale","planned":false,"acquired":false,"shares":1800,"price":64.73,"value":116514.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $64.61 to $64.95. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Balance includes 171 shares acquired under the Company's Employee Stock Purchase Plan."}],"balance_after":552283,"source":{"system":"sec-edgar","filing":"0001127602-23-010958","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1806431/000112760223010958/form4.xml","form_type":"4"}},{"id":1943185,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":34840,"kind":"person","name":"Hykes Andrew","position":1,"cik":"0001806431","reported_name":"Hykes Andrew","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-03-21T20:35:29.000Z","date":"2023-03-20","kind":"sale","planned":false,"acquired":false,"shares":7200,"price":64.18,"value":462096.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $63.58 to $64.57. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":554083,"source":{"system":"sec-edgar","filing":"0001127602-23-010958","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1806431/000112760223010958/form4.xml","form_type":"4"}},{"id":1954379,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":34840,"kind":"person","name":"Hykes Andrew","position":1,"cik":"0001806431","reported_name":"Hykes Andrew","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Restricted Stock Unit","published_at":"2023-03-14T23:08:05.000Z","date":"2023-03-12","kind":"exercise","acquired":false,"shares":430517,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Amount represents the vesting in full of restricted stock units (RSUs) granted under the 2011 Plan in August 2019 that were subject to achievement of certain conditions specified in the award agreement, including continued service to the company. 100% of the RSUs vested on the fourth anniversary of the vesting commencement date as all conditions were satisfied."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Amount represents the vesting in full of restricted stock units (RSUs) granted under the 2011 Plan in August 2019 that were subject to achievement of certain conditions specified in the award agreement, including continued service to the company. 100% of the RSUs vested on the fourth anniversary of the vesting commencement date as all conditions were satisfied."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":430517},"source":{"system":"sec-edgar","filing":"0001127602-23-010147","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1806431/000112760223010147/form4.xml","form_type":"4"}},{"id":1954378,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":34840,"kind":"person","name":"Hykes Andrew","position":1,"cik":"0001806431","reported_name":"Hykes Andrew","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-03-14T23:08:05.000Z","date":"2023-03-12","kind":"exercise","acquired":true,"shares":430517,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":561112,"source":{"system":"sec-edgar","filing":"0001127602-23-010147","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1806431/000112760223010147/form4.xml","form_type":"4"}},{"id":2000076,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":34840,"kind":"person","name":"Hykes Andrew","position":1,"cik":"0001806431","reported_name":"Hykes Andrew","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Stock Options (Right to Buy)","published_at":"2023-02-22T21:54:47.000Z","date":"2023-02-18","kind":"grant","acquired":true,"shares":36085,"price":56,"value":2020760.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These options were granted on February 18, 2023 under the Inari Medical, Inc. 2020 Incentive Award Plan and are scheduled to become vested and exercisable on a quarterly basis commencing April 1, 2023."}],"balance_after":36085,"derivative":{"exercise_price":56,"expiration_date":"2030-02-17","underlying":"Common Stock","underlying_shares":36085},"source":{"system":"sec-edgar","filing":"0001127602-23-006508","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1806431/000112760223006508/form4.xml","form_type":"4"}},{"id":2000075,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":34840,"kind":"person","name":"Hykes Andrew","position":1,"cik":"0001806431","reported_name":"Hykes Andrew","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-02-22T21:54:47.000Z","date":"2023-02-21","kind":"sale","acquired":false,"shares":9000,"price":55.19,"value":496710.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $55.00 to $55.57. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":130595,"source":{"system":"sec-edgar","filing":"0001127602-23-006508","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1806431/000112760223006508/form4.xml","form_type":"4"}},{"id":2000074,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":34840,"kind":"person","name":"Hykes Andrew","position":1,"cik":"0001806431","reported_name":"Hykes Andrew","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-02-22T21:54:47.000Z","date":"2023-02-18","kind":"grant","acquired":true,"shares":46549,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"2023 Annual Restricted Stock Units grant (\"RSUs\"). Vesting Commencement Date begins January 1, 2023, 1/16th of the RSUs shall vest on each quarterly anniversary of the vesting Commencement Date."}],"balance_after":139595,"source":{"system":"sec-edgar","filing":"0001127602-23-006508","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1806431/000112760223006508/form4.xml","form_type":"4"}},{"id":2047546,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":34840,"kind":"person","name":"Hykes Andrew","position":1,"cik":"0001806431","reported_name":"Hykes Andrew","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-01-24T22:45:52.000Z","date":"2023-01-20","kind":"sale","acquired":false,"shares":100,"price":62.66,"value":6266.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Balance includes 193 shares acquired under the Employee Stock Ownership Plan."}],"balance_after":93046,"source":{"system":"sec-edgar","filing":"0001127602-23-002143","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1806431/000112760223002143/form4.xml","form_type":"4"}},{"id":2047545,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":34840,"kind":"person","name":"Hykes Andrew","position":1,"cik":"0001806431","reported_name":"Hykes Andrew","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-01-24T22:45:52.000Z","date":"2023-01-20","kind":"sale","acquired":false,"shares":6900,"price":62.07,"value":428283.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $61.60 to $62.55. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":93146,"source":{"system":"sec-edgar","filing":"0001127602-23-002143","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1806431/000112760223002143/form4.xml","form_type":"4"}},{"id":2047544,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":34840,"kind":"person","name":"Hykes Andrew","position":1,"cik":"0001806431","reported_name":"Hykes Andrew","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-01-24T22:45:52.000Z","date":"2023-01-20","kind":"sale","acquired":false,"shares":2000,"price":61.29,"value":122580.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $60.59 to $61.57. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":100046,"source":{"system":"sec-edgar","filing":"0001127602-23-002143","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1806431/000112760223002143/form4.xml","form_type":"4"}},{"id":2068265,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":34840,"kind":"person","name":"Hykes Andrew","position":1,"cik":"0001806431","reported_name":"Hykes Andrew","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-01-04T23:41:34.000Z","date":"2023-01-01","kind":"tax_withholding","acquired":false,"shares":762,"price":63.56,"value":48432.72,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Consists of shares of common stock retained by Inari to satisfy the reporting person's tax obligation in connection with the vesting of restricted share units awarded in 2022."}],"balance_after":101853,"source":{"system":"sec-edgar","filing":"0001127602-23-000716","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1806431/000112760223000716/form4.xml","form_type":"4"}},{"id":2068264,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":34840,"kind":"person","name":"Hykes Andrew","position":1,"cik":"0001806431","reported_name":"Hykes Andrew","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-01-04T23:41:34.000Z","date":"2023-01-01","kind":"tax_withholding","acquired":false,"shares":383,"price":63.56,"value":24343.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of shares of common stock retained by Inari to satisfy the reporting person's tax obligation in connection with the vesting of restricted share units awarded in 2021."}],"balance_after":102615,"source":{"system":"sec-edgar","filing":"0001127602-23-000716","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1806431/000112760223000716/form4.xml","form_type":"4"}},{"id":2077709,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":34840,"kind":"person","name":"Hykes Andrew","position":1,"cik":"0001806431","reported_name":"Hykes Andrew","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2022-12-22T21:31:42.000Z","date":"2022-12-20","kind":"sale","acquired":false,"shares":4090,"price":69,"value":282210.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $68.74 to $69.67. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":102998,"source":{"system":"sec-edgar","filing":"0001127602-22-028160","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1806431/000112760222028160/form4.xml","form_type":"4"}},{"id":2077708,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":34840,"kind":"person","name":"Hykes Andrew","position":1,"cik":"0001806431","reported_name":"Hykes Andrew","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2022-12-22T21:31:42.000Z","date":"2022-12-20","kind":"sale","acquired":false,"shares":4010,"price":68.28,"value":273802.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $67.73 to $68.70. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":107088,"source":{"system":"sec-edgar","filing":"0001127602-22-028160","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1806431/000112760222028160/form4.xml","form_type":"4"}},{"id":2077707,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":34840,"kind":"person","name":"Hykes Andrew","position":1,"cik":"0001806431","reported_name":"Hykes Andrew","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2022-12-22T21:31:42.000Z","date":"2022-12-20","kind":"sale","acquired":false,"shares":900,"price":67.16,"value":60444.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $66.65 to $67.60. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":111098,"source":{"system":"sec-edgar","filing":"0001127602-22-028160","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1806431/000112760222028160/form4.xml","form_type":"4"}},{"id":2107034,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":34840,"kind":"person","name":"Hykes Andrew","position":1,"cik":"0001806431","reported_name":"Hykes Andrew","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2022-11-22T21:35:29.000Z","date":"2022-11-21","kind":"sale","acquired":false,"shares":3989,"price":77.9,"value":310743.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $77.69 to $78.36. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":111998,"source":{"system":"sec-edgar","filing":"0001127602-22-026266","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1806431/000112760222026266/form4.xml","form_type":"4"}},{"id":2107033,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":34840,"kind":"person","name":"Hykes Andrew","position":1,"cik":"0001806431","reported_name":"Hykes Andrew","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2022-11-22T21:35:29.000Z","date":"2022-11-21","kind":"sale","acquired":false,"shares":5011,"price":77.46,"value":388152.06,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $76.69 to $77.68. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":115987,"source":{"system":"sec-edgar","filing":"0001127602-22-026266","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1806431/000112760222026266/form4.xml","form_type":"4"}},{"id":2133025,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":34840,"kind":"person","name":"Hykes Andrew","position":1,"cik":"0001806431","reported_name":"Hykes Andrew","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2022-10-24T21:20:20.000Z","date":"2022-10-20","kind":"sale","acquired":false,"shares":400,"price":73.88,"value":29552.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $73.79 to $74.08. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":120998,"source":{"system":"sec-edgar","filing":"0001127602-22-024305","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1806431/000112760222024305/form4.xml","form_type":"4"}},{"id":2133024,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":34840,"kind":"person","name":"Hykes Andrew","position":1,"cik":"0001806431","reported_name":"Hykes Andrew","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2022-10-24T21:20:20.000Z","date":"2022-10-20","kind":"sale","acquired":false,"shares":2565,"price":73.14,"value":187604.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $72.75 to $73.67. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":121398,"source":{"system":"sec-edgar","filing":"0001127602-22-024305","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1806431/000112760222024305/form4.xml","form_type":"4"}},{"id":2133023,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":34840,"kind":"person","name":"Hykes Andrew","position":1,"cik":"0001806431","reported_name":"Hykes Andrew","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2022-10-24T21:20:20.000Z","date":"2022-10-20","kind":"sale","acquired":false,"shares":4491,"price":72.04,"value":323531.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $71.75 to $72.66. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":123963,"source":{"system":"sec-edgar","filing":"0001127602-22-024305","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1806431/000112760222024305/form4.xml","form_type":"4"}},{"id":2133022,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":34840,"kind":"person","name":"Hykes Andrew","position":1,"cik":"0001806431","reported_name":"Hykes Andrew","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2022-10-24T21:20:20.000Z","date":"2022-10-20","kind":"sale","acquired":false,"shares":1544,"price":71.45,"value":110318.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $70.74 to $71.72. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":128454,"source":{"system":"sec-edgar","filing":"0001127602-22-024305","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1806431/000112760222024305/form4.xml","form_type":"4"}},{"id":2144890,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":34840,"kind":"person","name":"Hykes Andrew","position":1,"cik":"0001806431","reported_name":"Hykes Andrew","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2022-10-04T21:34:02.000Z","date":"2022-10-01","kind":"tax_withholding","acquired":false,"shares":646,"price":72.64,"value":46925.44,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Consists of shares of common stock retained by Inari to satisfy the reporting person's tax obligation in connection with the vesting of restricted share units awarded in 2022."}],"balance_after":129998,"source":{"system":"sec-edgar","filing":"0001127602-22-023558","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1806431/000112760222023558/form4.xml","form_type":"4"}},{"id":2144889,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":34840,"kind":"person","name":"Hykes Andrew","position":1,"cik":"0001806431","reported_name":"Hykes Andrew","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2022-10-04T21:34:02.000Z","date":"2022-10-01","kind":"tax_withholding","acquired":false,"shares":347,"price":72.64,"value":25206.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of shares of common stock retained by Inari to satisfy the reporting person's tax obligation in connection with the vesting of restricted share units awarded in 2021."}],"balance_after":130644,"source":{"system":"sec-edgar","filing":"0001127602-22-023558","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1806431/000112760222023558/form4.xml","form_type":"4"}},{"id":2163195,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":34840,"kind":"person","name":"Hykes Andrew","position":1,"cik":"0001806431","reported_name":"Hykes Andrew","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2022-09-08T21:37:00.000Z","date":"2022-09-06","kind":"sale","acquired":false,"shares":5000,"price":70,"value":350000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2021."}],"balance_after":130991,"source":{"system":"sec-edgar","filing":"0001127602-22-022216","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1806431/000112760222022216/form4.xml","form_type":"4"}},{"id":2195945,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":34840,"kind":"person","name":"Hykes Andrew","position":1,"cik":"0001806431","reported_name":"Hykes Andrew","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2022-08-03T20:30:55.000Z","date":"2022-08-01","kind":"sale","acquired":false,"shares":61,"price":79.92,"value":4875.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2021."}],"balance_after":135991,"source":{"system":"sec-edgar","filing":"0001127602-22-020367","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1806431/000112760222020367/form4.xml","form_type":"4"}},{"id":2195944,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":34840,"kind":"person","name":"Hykes Andrew","position":1,"cik":"0001806431","reported_name":"Hykes Andrew","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2022-08-03T20:30:55.000Z","date":"2022-08-01","kind":"sale","acquired":false,"shares":3604,"price":79.19,"value":285400.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $78.70 to $79.63. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":136052,"source":{"system":"sec-edgar","filing":"0001127602-22-020367","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1806431/000112760222020367/form4.xml","form_type":"4"}},{"id":2195943,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":34840,"kind":"person","name":"Hykes Andrew","position":1,"cik":"0001806431","reported_name":"Hykes Andrew","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2022-08-03T20:30:55.000Z","date":"2022-08-01","kind":"sale","acquired":false,"shares":435,"price":77.87,"value":33873.45,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $77.62 to $78.55. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":139656,"source":{"system":"sec-edgar","filing":"0001127602-22-020367","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1806431/000112760222020367/form4.xml","form_type":"4"}},{"id":2195942,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":34840,"kind":"person","name":"Hykes Andrew","position":1,"cik":"0001806431","reported_name":"Hykes Andrew","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2022-08-03T20:30:55.000Z","date":"2022-08-01","kind":"sale","acquired":false,"shares":900,"price":76.9,"value":69210.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $76.61 to $77.17. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":140091,"source":{"system":"sec-edgar","filing":"0001127602-22-020367","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1806431/000112760222020367/form4.xml","form_type":"4"}},{"id":2212126,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":34840,"kind":"person","name":"Hykes Andrew","position":1,"cik":"0001806431","reported_name":"Hykes Andrew","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2022-07-06T22:17:49.000Z","date":"2022-07-05","kind":"sale","acquired":false,"shares":5000,"price":70.31,"value":351550.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $70.00 to $70.72. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":140991,"source":{"system":"sec-edgar","filing":"0001127602-22-019006","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1806431/000112760222019006/form4.xml","form_type":"4"}},{"id":2212125,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":34840,"kind":"person","name":"Hykes Andrew","position":1,"cik":"0001806431","reported_name":"Hykes Andrew","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2022-07-06T22:17:49.000Z","date":"2022-07-01","kind":"tax_withholding","acquired":false,"shares":646,"price":68.66,"value":44354.36,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Consists of shares of common stock retained by Inari to satisfy the reporting person's tax obligation in connection with the vesting of restricted share units awarded in 2022."}],"balance_after":145991,"source":{"system":"sec-edgar","filing":"0001127602-22-019006","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1806431/000112760222019006/form4.xml","form_type":"4"}},{"id":2212124,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":34840,"kind":"person","name":"Hykes Andrew","position":1,"cik":"0001806431","reported_name":"Hykes Andrew","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2022-07-06T22:17:49.000Z","date":"2022-07-01","kind":"tax_withholding","acquired":false,"shares":347,"price":68.66,"value":23825.02,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of shares of common stock retained by Inari to satisfy the reporting person's tax obligation in connection with the vesting of restricted share units awarded in 2021."}],"balance_after":146637,"source":{"system":"sec-edgar","filing":"0001127602-22-019006","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1806431/000112760222019006/form4.xml","form_type":"4"}},{"id":2237926,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":34840,"kind":"person","name":"Hykes Andrew","position":1,"cik":"0001806431","reported_name":"Hykes Andrew","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2022-06-09T20:34:12.000Z","date":"2022-06-07","kind":"sale","acquired":false,"shares":5000,"price":70.078,"value":350390.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $70.00 to $70.20. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":146984,"source":{"system":"sec-edgar","filing":"0001127602-22-017136","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1806431/000112760222017136/form4.xml","form_type":"4"}},{"id":2282412,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":34840,"kind":"person","name":"Hykes Andrew","position":1,"cik":"0001806431","reported_name":"Hykes Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2022-05-04T20:33:02.000Z","date":"2022-05-02","kind":"sale","acquired":false,"shares":100,"price":81.75,"value":8175.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2021."}],"balance_after":151984,"source":{"system":"sec-edgar","filing":"0001562180-22-003739","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1806431/000156218022003739/primarydocument.xml","form_type":"4"}}],"next_cursor":"2022-05-04T20:33:02.000000Z,2282412"}